Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP977124.RAOu5wb_-Bk0JGJuzAjkzymuHp_wsb3cPZPEN2RjoWsZ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP977124.RAOu5wb_-Bk0JGJuzAjkzymuHp_wsb3cPZPEN2RjoWsZ0130_assertion type Assertion NP977124.RAOu5wb_-Bk0JGJuzAjkzymuHp_wsb3cPZPEN2RjoWsZ0130_head.
- NP977124.RAOu5wb_-Bk0JGJuzAjkzymuHp_wsb3cPZPEN2RjoWsZ0130_assertion description "[The host conditioning with low-dose basiliximab may augment the efficacy of AIT for cancer using activated autologous lymphocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977124.RAOu5wb_-Bk0JGJuzAjkzymuHp_wsb3cPZPEN2RjoWsZ0130_provenance.
- NP977124.RAOu5wb_-Bk0JGJuzAjkzymuHp_wsb3cPZPEN2RjoWsZ0130_assertion evidence source_evidence_literature NP977124.RAOu5wb_-Bk0JGJuzAjkzymuHp_wsb3cPZPEN2RjoWsZ0130_provenance.
- NP977124.RAOu5wb_-Bk0JGJuzAjkzymuHp_wsb3cPZPEN2RjoWsZ0130_assertion SIO_000772 19148493 NP977124.RAOu5wb_-Bk0JGJuzAjkzymuHp_wsb3cPZPEN2RjoWsZ0130_provenance.
- NP977124.RAOu5wb_-Bk0JGJuzAjkzymuHp_wsb3cPZPEN2RjoWsZ0130_assertion wasDerivedFrom befree-20150227 NP977124.RAOu5wb_-Bk0JGJuzAjkzymuHp_wsb3cPZPEN2RjoWsZ0130_provenance.
- NP977124.RAOu5wb_-Bk0JGJuzAjkzymuHp_wsb3cPZPEN2RjoWsZ0130_assertion wasGeneratedBy ECO_0000203 NP977124.RAOu5wb_-Bk0JGJuzAjkzymuHp_wsb3cPZPEN2RjoWsZ0130_provenance.